HIGHLIGHTS
- who: Takafumi Koyauchi from the University School of Medicine, u201120u2011, Handayama, Higashi Ward, Hamamatsu, Shizuoka, u20113192, Japan have published the research work: Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study, in the Journal: (JOURNAL)
- what: This study also showed that patients treated with IMV at the end of life had the lowest QODD score in the respiratory modality groups. The authors believe the findings of this study have a degree of external validity since many . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.